GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 32 filers reported holding GALMED PHARMACEUTICALS LTD in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $26,000 | – | 4,629 | +10186.7% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 45 | -99.9% | 0.00% | – |
| Q2 2019 | $237,000 | -11.2% | 32,300 | -1.5% | 0.00% | – |
| Q1 2019 | $267,000 | +16.6% | 32,800 | -2.4% | 0.00% | – |
| Q4 2018 | $229,000 | -42.5% | 33,600 | -53.1% | 0.00% | – |
| Q1 2018 | $398,000 | +61.8% | 71,585 | +165.6% | 0.00% | – |
| Q4 2017 | $246,000 | +969.6% | 26,949 | +418.2% | 0.00% | – |
| Q2 2016 | $23,000 | -20.7% | 5,200 | +65.7% | 0.00% | – |
| Q1 2015 | $29,000 | -85.1% | 3,139 | -84.3% | 0.00% | – |
| Q2 2014 | $194,000 | -15.3% | 20,000 | 0.0% | 0.00% | – |
| Q1 2014 | $229,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,799,694 | $1,224,000 | 0.06% |
| BRAVE ASSET MANAGEMENT INC | 11,470 | $8,000 | 0.00% |
| Western Wealth Management, LLC | 59,074 | $38,000 | 0.00% |
| PYA Waltman Capital, LLC | 1,000 | $1,000 | 0.00% |
| TSFG, LLC | 3,000 | $2,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 27,177 | $18,000 | 0.00% |
| Renaissance Technologies | 31,600 | $21,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 50,748 | $35,000 | 0.00% |
| CITIGROUP INC | 3,700 | $3,000 | 0.00% |
| UBS Group AG | 6,064 | $4,000 | 0.00% |